76.99
price down icon1.00%   -0.78
after-market Dopo l'orario di chiusura: 77.54 0.55 +0.71%
loading
Precedente Chiudi:
$77.77
Aprire:
$76.74
Volume 24 ore:
1.07M
Relative Volume:
0.62
Capitalizzazione di mercato:
$13.94B
Reddito:
$342.96M
Utile/perdita netta:
$-864.29M
Rapporto P/E:
-13.87
EPS:
-5.55
Flusso di cassa netto:
$-636.03M
1 W Prestazione:
+4.46%
1M Prestazione:
-5.37%
6M Prestazione:
+5.65%
1 anno Prestazione:
+194.53%
Intervallo 1D:
Value
$75.81
$77.76
Intervallo di 1 settimana:
Value
$73.01
$78.18
Portata 52W:
Value
$21.92
$84.91

Insmed Inc Stock (INSM) Company Profile

Name
Nome
Insmed Inc
Name
Telefono
908-977-9900
Name
Indirizzo
700 US HIGHWAY 202/206, BRIDGEWATER, NJ
Name
Dipendente
1,271
Name
Cinguettio
@insmed
Name
Prossima data di guadagno
2024-10-31
Name
Ultimi documenti SEC
Name
INSM's Discussions on Twitter

Confronta INSM con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
INSM
Insmed Inc
76.99 13.94B 342.96M -864.29M -636.03M -5.55
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
512.23 131.54B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
664.96 72.70B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
611.18 37.14B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
244.30 31.63B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
261.38 28.10B 3.32B -860.46M -1.04B -8.32

Insmed Inc Stock (INSM) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-02-25 Iniziato RBC Capital Mkts Outperform
2024-04-23 Iniziato Truist Buy
2024-02-15 Iniziato Wolfe Research Outperform
2023-12-08 Iniziato Wells Fargo Overweight
2023-11-20 Ripresa JP Morgan Overweight
2023-07-26 Iniziato Guggenheim Buy
2022-12-09 Iniziato Mizuho Buy
2022-12-07 Iniziato Barclays Overweight
2022-11-18 Iniziato BofA Securities Buy
2022-04-27 Iniziato Goldman Buy
2021-12-06 Iniziato JP Morgan Overweight
2021-10-19 Ripresa Monness Crespi & Hardt Buy
2021-10-19 Ripresa Morgan Stanley Overweight
2021-10-08 Iniziato Cantor Fitzgerald Overweight
2021-04-26 Ripresa Credit Suisse Outperform
2020-12-17 Iniziato Berenberg Buy
2020-10-12 Ripresa Stifel Buy
2019-09-03 Iniziato Goldman Buy
2019-04-09 Reiterato H.C. Wainwright Buy
2019-02-15 Aggiornamento JMP Securities Mkt Perform → Mkt Outperform
2019-01-17 Aggiornamento Goldman Neutral → Buy
2019-01-02 Iniziato Canaccord Genuity Buy
2018-08-06 Downgrade JMP Securities Mkt Outperform → Mkt Perform
2018-07-23 Iniziato Goldman Neutral
2018-04-23 Aggiornamento Credit Suisse Neutral → Outperform
2018-03-21 Iniziato Morgan Stanley Overweight
2018-01-18 Iniziato Credit Suisse Neutral
2017-09-05 Reiterato Evercore ISI Outperform
2017-08-17 Iniziato Evercore ISI Outperform
2017-07-11 Iniziato Robert W. Baird Outperform
2016-03-15 Iniziato Stifel Buy
2015-11-09 Downgrade UBS Buy → Neutral
2015-10-06 Reiterato H.C. Wainwright Buy
2015-06-09 Iniziato Citigroup Neutral
2014-03-26 Reiterato HC Wainwright Buy
Mostra tutto

Insmed Inc Borsa (INSM) Ultime notizie

pulisher
Mar 17, 2025

Is Insmed Incorporated (INSM) a Best Biotech Stock According to Billionaires? - Yahoo Finance

Mar 17, 2025
pulisher
Mar 15, 2025

15 Best Biotech Stocks to Buy According to Billionaires - Insider Monkey

Mar 15, 2025
pulisher
Mar 12, 2025

Truist maintains Buy on Insmed stock, sees PAH data as positive - Investing.com Australia

Mar 12, 2025
pulisher
Mar 12, 2025

US Bancorp DE Boosts Holdings in Insmed Incorporated (NASDAQ:INSM) - Defense World

Mar 12, 2025
pulisher
Mar 12, 2025

Truist maintains Buy on Insmed stock, sees PAH data as positive By Investing.com - Investing.com South Africa

Mar 12, 2025
pulisher
Mar 11, 2025

Insmed at Leerink Global Healthcare Conference: Optimism for Brenzo’s Launch By Investing.com - Investing.com South Africa

Mar 11, 2025
pulisher
Mar 11, 2025

Insider Sell: Roger Adsett Sells 42,975 Shares of Insmed Inc (IN - GuruFocus.com

Mar 11, 2025
pulisher
Mar 11, 2025

Insmed at Leerink Global Healthcare Conference: Optimism for Brenzo’s Launch - Investing.com

Mar 11, 2025
pulisher
Mar 11, 2025

Insmed Incorporated (NASDAQ:INSM) Shares Acquired by Smartleaf Asset Management LLC - Defense World

Mar 11, 2025
pulisher
Mar 10, 2025

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Citizentribune

Mar 10, 2025
pulisher
Mar 10, 2025

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) -March 10, 2025 at 08:01 am EDT - Marketscreener.com

Mar 10, 2025
pulisher
Mar 10, 2025

Insmed Expands Team with Stock Options Grant to 18 New Hires - StockTitan

Mar 10, 2025
pulisher
Mar 08, 2025

UBS Group Raises Insmed (NASDAQ:INSM) Price Target to $110.00 - Defense World

Mar 08, 2025
pulisher
Mar 07, 2025

Insmed’s Strategic Growth and Promising Pipeline Drive Buy Rating - TipRanks

Mar 07, 2025
pulisher
Mar 06, 2025

UBS raises Insmed stock price target to $110 By Investing.com - Investing.com UK

Mar 06, 2025
pulisher
Mar 06, 2025

Insmed CEO Lewis sells $1.99 million in stock By Investing.com - Investing.com Australia

Mar 06, 2025
pulisher
Mar 05, 2025

Insmed CEO Lewis sells $1.99 million in stock - Investing.com India

Mar 05, 2025
pulisher
Mar 05, 2025

Amalgamated Bank Boosts Stake in Insmed Incorporated (NASDAQ:INSM) - Defense World

Mar 05, 2025
pulisher
Mar 05, 2025

Sanctuary Advisors LLC Acquires 464 Shares of Insmed Incorporated (NASDAQ:INSM) - Defense World

Mar 05, 2025
pulisher
Mar 01, 2025

Insmed, Agios rise; DraftKings, Atlantica fall, Tuesday, 5/28/2024 - Star Tribune

Mar 01, 2025
pulisher
Mar 01, 2025

RBC Capital starts Insmed at Outperform on brensocatib launch momentum - MSN

Mar 01, 2025
pulisher
Mar 01, 2025

Guggenheim Reaffirms Buy Rating for Insmed (NASDAQ:INSM) - MarketBeat

Mar 01, 2025
pulisher
Feb 28, 2025

Investor Network: Insmed Incorporated to Host Earnings Call - ACCESS Newswire

Feb 28, 2025
pulisher
Feb 27, 2025

Major Public Health Interest? Scholar, Insmed & Soleno Ask EMA To Fast-Track Their Products - Pink Sheet

Feb 27, 2025
pulisher
Feb 27, 2025

Truist Financial Corp Boosts Stake in Insmed Incorporated (NASDAQ:INSM) - Defense World

Feb 27, 2025
pulisher
Feb 27, 2025

Insmed (NASDAQ:INSM) Now Covered by Royal Bank of Canada - MarketBeat

Feb 27, 2025
pulisher
Feb 26, 2025

Insmed's Q4 Loss Wider Than Expected, Sales In Line With Estimates - MSN

Feb 26, 2025
pulisher
Feb 26, 2025

RBC Capital Initiates Coverage of Insmed (LSE:0JAV) with Outperform Recommendation - Nasdaq

Feb 26, 2025
pulisher
Feb 26, 2025

Lung Disease-Focused Insmed 'Is An Attractive Midcap Biotech,' Analyst Says - Benzinga India

Feb 26, 2025
pulisher
Feb 25, 2025

RBC Capital sets $100 price target on Insmed stock with Outperform rating - Investing.com Canada

Feb 25, 2025
pulisher
Feb 25, 2025

RBC Capital Initiates Coverage of Insmed (INSM) with Outperform Recommendation - MSN

Feb 25, 2025
pulisher
Feb 25, 2025

This Insmed Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Benzinga

Feb 25, 2025
pulisher
Feb 25, 2025

Insmed to Benefit From Strong Launch of Brensocatib for Lung Disease, RBC Says -February 25, 2025 at 12:09 pm EST - Marketscreener.com

Feb 25, 2025
pulisher
Feb 24, 2025

FDA sets PDUFA date for Insmed's bronchiectasis drug By Investing.com - Investing.com Australia

Feb 24, 2025
pulisher
Feb 24, 2025

FDA sets PDUFA date for Insmed’s bronchiectasis drug By Investing.com - Investing.com Nigeria

Feb 24, 2025
pulisher
Feb 24, 2025

Insmed’s Brensocatib Receives FDA Priority Review - TipRanks

Feb 24, 2025
pulisher
Feb 24, 2025

International Markets and Insmed (INSM): A Deep Dive for Investors - Yahoo Finance

Feb 24, 2025
pulisher
Feb 24, 2025

FDA sets PDUFA date for Insmed's bronchiectasis drug - Investing.com India

Feb 24, 2025
pulisher
Feb 24, 2025

FDA sets PDUFA date for Insmed’s bronchiectasis drug - Investing.com

Feb 24, 2025
pulisher
Feb 24, 2025

Could This Novel Drug Transform Bronchiectasis Treatment? FDA Signals Confidence in Brensocatib - StockTitan

Feb 24, 2025
pulisher
Feb 23, 2025

Insider Sell: Sara Bonstein Sells 18,322 Shares of Insmed Inc (I - GuruFocus.com

Feb 23, 2025
pulisher
Feb 23, 2025

Truist Financial Increases Insmed (NASDAQ:INSM) Price Target to $108.00 - Defense World

Feb 23, 2025
pulisher
Feb 22, 2025

UBS raises Insmed stock target to $105, maintains buy rating By Investing.com - Investing.com Nigeria

Feb 22, 2025
pulisher
Feb 21, 2025

Insmed’s Earnings Call Highlights Record Growth and Strategic Moves - TipRanks

Feb 21, 2025
pulisher
Feb 21, 2025

Insmed (NASDAQ:INSM) Shares Gap Down on Disappointing Earnings - MarketBeat

Feb 21, 2025
pulisher
Feb 21, 2025

UBS Adjusts Insmed Price Target to $105 From $84, Maintains Buy Rating -February 21, 2025 at 10:46 am EST - Marketscreener.com

Feb 21, 2025
pulisher
Feb 21, 2025

Insmed Inc (INSM) Q4 2024 Earnings Call Highlights: Record Reven - GuruFocus.com

Feb 21, 2025
pulisher
Feb 21, 2025

UBS raises Insmed stock target to $105, maintains buy rating - Investing.com India

Feb 21, 2025

Insmed Inc Azioni (INSM) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Insmed Inc Azioni (INSM) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Lewis William
Chair and CEO
Mar 03 '25
Option Exercise
22.76
18,750
426,750
352,936
Lewis William
Chair and CEO
Mar 03 '25
Option Exercise
10.85
6,830
74,106
240,754
Lewis William
Chair and CEO
Mar 03 '25
Sale
77.79
18,750
1,458,519
334,186
Lewis William
Chair and CEO
Mar 03 '25
Sale
77.79
6,830
531,278
233,924
$314.12
price down icon 2.73%
$33.41
price up icon 1.18%
$19.83
price down icon 1.49%
$98.96
price down icon 1.88%
biotechnology ONC
$261.38
price down icon 1.39%
Capitalizzazione:     |  Volume (24 ore):